ADIAL PHARMACEUTICALS INC (ADIL) Stock Income Statement
NASDAQ:ADIL • US00688A3041
Current stock price
1.85 USD
-0.11 (-5.61%)
At close:
1.8555 USD
+0.01 (+0.3%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.80M | 8.28M | 6.89M | 13.32M | 17.74M | |||
| Research and Development | 2.62M | 3.23M | 1.27M | 4.18M | 8.40M | |||
| Selling, General, and Administrative Expenses | 5.18M | 5.06M | 5.62M | 9.14M | 9.34M | |||
| Operating Income | -7.80M | -8.28M | -6.89M | -13.32M | -17.74M | |||
| Interest Income/Expense | -342.60K | -373.50K | -124.10K | 60.00K | 10.00K | |||
| Other Income/Expense | 164.90K | -4.54M | 10.20K | 520.00K | -260.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -1.52M | |||
| Income Before Taxes | -7.98M | -13.20M | -7.00M | -12.73M | -19.52M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | -90.00K | |||
| Net Income | -7.98M | -13.20M | -5.12M | -12.73M | -19.42M | |||
| EBITDA | -7.80M | -8.28M | -6.89M | -13.31M | -17.73M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.93 | -68.01 | -89.89 | -12.71 | -26.24 | |||
| Non GAAP EPS | -9.91 | -1.94 | -4.32 | -13.00 | N/A | |||
| Statistics | ||||||||
All data in USD